Richard Newitter
Stock Analyst at Truist Securities
(4.38)
# 492
Out of 4,641 analysts
334
Total ratings
55.21%
Success rate
15.76%
Average return
Main Sectors:
Stocks Rated by Richard Newitter
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
IRTC iRhythm Technologies | Maintains: Buy | $80 → $95 | $74.36 | +27.76% | 14 | Oct 22, 2024 | |
TMCI Treace Medical Concepts | Maintains: Hold | $7.5 → $6 | $5.08 | +18.11% | 10 | Oct 14, 2024 | |
TFX Teleflex | Maintains: Hold | $247 → $255 | $237.82 | +7.22% | 33 | Oct 14, 2024 | |
SYK Stryker | Maintains: Hold | $345 → $370 | $363.24 | +1.86% | 16 | Oct 14, 2024 | |
PEN Penumbra | Maintains: Buy | $200 → $235 | $203.71 | +15.36% | 4 | Oct 14, 2024 | |
KIDS OrthoPediatrics | Maintains: Hold | $34 → $28 | $25.82 | +8.44% | 8 | Oct 14, 2024 | |
MDT Medtronic | Maintains: Hold | $90 → $93 | $92.27 | +0.79% | 13 | Oct 14, 2024 | |
ISRG Intuitive Surgical | Maintains: Buy | $520 → $570 | $512.58 | +11.20% | 24 | Oct 14, 2024 | |
IART Integra LifeSciences Holdings | Maintains: Hold | $26 → $21 | $19.11 | +9.89% | 17 | Oct 14, 2024 | |
ITGR Integer Holdings | Maintains: Buy | $145 → $150 | $126.53 | +18.55% | 3 | Oct 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $55 → $46 | $44.11 | +4.28% | 13 | Oct 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $145 → $152 | $129.94 | +16.98% | 2 | Oct 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $100 | $87.45 | +14.35% | 9 | Oct 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $217 → $240 | $192.47 | +24.69% | 23 | Sep 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $117 → $112 | $104.70 | +6.97% | 29 | Sep 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $82 → $71 | $70.61 | +0.55% | 15 | Sep 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $74 → $95 | $67.32 | +41.12% | 11 | Sep 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $10 → $5.5 | $4.90 | +12.24% | 10 | Aug 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $78 → $79 | $73.89 | +6.92% | 23 | Aug 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $141 → $135 | $110.64 | +22.02% | 15 | Aug 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $25 → $29 | $42.28 | -31.41% | 1 | Jan 31, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $21 | $12.74 | +64.84% | 1 | Jan 31, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $80 | $70.27 | +13.85% | 3 | Oct 17, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $48.51 | -58.77% | 1 | Aug 24, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $71 → $82 | $94.51 | -13.24% | 5 | Aug 19, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $260 → $250 | $240.52 | +3.94% | 5 | Aug 6, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $27 → $26 | $2.89 | +799.65% | 4 | May 11, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $690 → $770 | $207.66 | +270.80% | 10 | Apr 29, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $94 → $85 | $81.35 | +4.49% | 6 | Apr 29, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $5.60 | +257.14% | 1 | Feb 24, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $27 | $13.12 | +105.79% | 5 | Feb 23, 2021 |
iRhythm Technologies
Oct 22, 2024
Maintains: Buy
Price Target: $80 → $95
Current: $74.36
Upside: +27.76%
Treace Medical Concepts
Oct 14, 2024
Maintains: Hold
Price Target: $7.5 → $6
Current: $5.08
Upside: +18.11%
Teleflex
Oct 14, 2024
Maintains: Hold
Price Target: $247 → $255
Current: $237.82
Upside: +7.22%
Stryker
Oct 14, 2024
Maintains: Hold
Price Target: $345 → $370
Current: $363.24
Upside: +1.86%
Penumbra
Oct 14, 2024
Maintains: Buy
Price Target: $200 → $235
Current: $203.71
Upside: +15.36%
OrthoPediatrics
Oct 14, 2024
Maintains: Hold
Price Target: $34 → $28
Current: $25.82
Upside: +8.44%
Medtronic
Oct 14, 2024
Maintains: Hold
Price Target: $90 → $93
Current: $92.27
Upside: +0.79%
Intuitive Surgical
Oct 14, 2024
Maintains: Buy
Price Target: $520 → $570
Current: $512.58
Upside: +11.20%
Integra LifeSciences Holdings
Oct 14, 2024
Maintains: Hold
Price Target: $26 → $21
Current: $19.11
Upside: +9.89%
Integer Holdings
Oct 14, 2024
Maintains: Buy
Price Target: $145 → $150
Current: $126.53
Upside: +18.55%
Oct 14, 2024
Maintains: Hold
Price Target: $55 → $46
Current: $44.11
Upside: +4.28%
Oct 14, 2024
Maintains: Buy
Price Target: $145 → $152
Current: $129.94
Upside: +16.98%
Oct 14, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $87.45
Upside: +14.35%
Sep 30, 2024
Reiterates: Buy
Price Target: $217 → $240
Current: $192.47
Upside: +24.69%
Sep 13, 2024
Reiterates: Hold
Price Target: $117 → $112
Current: $104.70
Upside: +6.97%
Sep 13, 2024
Maintains: Hold
Price Target: $82 → $71
Current: $70.61
Upside: +0.55%
Sep 3, 2024
Maintains: Buy
Price Target: $74 → $95
Current: $67.32
Upside: +41.12%
Aug 8, 2024
Maintains: Hold
Price Target: $10 → $5.5
Current: $4.90
Upside: +12.24%
Aug 7, 2024
Maintains: Hold
Price Target: $78 → $79
Current: $73.89
Upside: +6.92%
Aug 1, 2024
Maintains: Buy
Price Target: $141 → $135
Current: $110.64
Upside: +22.02%
Jan 31, 2023
Maintains: Hold
Price Target: $25 → $29
Current: $42.28
Upside: -31.41%
Jan 31, 2023
Maintains: Buy
Price Target: $17 → $21
Current: $12.74
Upside: +64.84%
Oct 17, 2022
Maintains: Buy
Price Target: $85 → $80
Current: $70.27
Upside: +13.85%
Aug 24, 2021
Initiates: Outperform
Price Target: $20
Current: $48.51
Upside: -58.77%
Aug 19, 2021
Maintains: Market Perform
Price Target: $71 → $82
Current: $94.51
Upside: -13.24%
Aug 6, 2021
Maintains: Market Perform
Price Target: $260 → $250
Current: $240.52
Upside: +3.94%
May 11, 2021
Maintains: Outperform
Price Target: $27 → $26
Current: $2.89
Upside: +799.65%
Apr 29, 2021
Maintains: Outperform
Price Target: $690 → $770
Current: $207.66
Upside: +270.80%
Apr 29, 2021
Maintains: Outperform
Price Target: $94 → $85
Current: $81.35
Upside: +4.49%
Feb 24, 2021
Initiates: Outperform
Price Target: $20
Current: $5.60
Upside: +257.14%
Feb 23, 2021
Maintains: Outperform
Price Target: $23 → $27
Current: $13.12
Upside: +105.79%